Alcohol Use Disorder (AUD) affects 6.7% of drinking adults. Some of the symptoms of AUD, as listed by the National Institute on Alcohol Abuse and Alcoholism (NIAAA), include being unable to reduce alcohol use despite a desire to do so, a need to drink that has become distracting, continuing to drink despite harm caused and experiencing symptoms of withdrawal […]

Ophthalmology is approaching a Renaissance as novel therapies are being developed to meet a variety of unmet needs that, with current therapies, may progress to blindness. Oculis S.A. entered this space a few years ago, determined to identify those gaps. Rather than begin with a solution in search of a problem, it started with a thorough […]

Amyotrophic lateral sclerosis (ALS) is a devastating disease. For years, pharmaceutical companies have been striving to develop therapies to help patients who face certain death but have mostly come up short. Now though, there is a renaissance in ALS drug development with multiple shots being taken on goal, including Clene, Inc.’s add-on treatment, CNM-Au8, which is […]